Nurse practitioners are just as good as primary care doctors at avoiding potentially harmful prescriptions for older patients—but both need to do better, a large, new study suggests.
Oct 28, 2023
0
1
The incidence rate of abortions decreased during the COVID-19 pandemic, mainly driven by procedural abortions, according to a study published online Oct. 24 in the Annals of Internal Medicine.
Oct 24, 2023
0
0
A study of more than 73,000 primary care physicians (PCPs) and nurse practitioners (NPs) suggest that both are similarly likely to inappropriately prescribe medications to older patients. According to the authors, this study ...
Oct 23, 2023
0
13
A study of health systems' websites has found that despite being a routine procedure at many hospitals, abortion is not mentioned by almost 80% of health system websites. The research report is published in Annals of Internal ...
Oct 16, 2023
0
0
In a brief research report, authors from University of Washington report that screening for opioid use disorder (OUD) in a primary care setting did not significantly boost the percentage of new diagnoses. Screening sensitivity ...
Oct 16, 2023
0
0
A study of more than 1 million adults has found that in primary care, telemedicine visits were comparable to in-person visits for addressing most patient clinical concern areas. Telemedicine visits resulted in lower treatment ...
Oct 16, 2023
0
0
Models built on machine learning in health care can be victims of their own success, according to researchers at the Icahn School of Medicine and the University of Michigan. Their study assessed the impact of implementing ...
Oct 9, 2023
0
40
A study of more than 850,000 children born in Australia found that parental infertility may be a factor for a small increased risk of birth defects in children conceived through fertility treatment. The authors also found ...
Oct 9, 2023
0
14
In a new Annals 'Beyond the Guideline's feature, two experts review the available evidence about cognitive impairment to determine effective screening tools, interventions to improve patient outcomes, and the circumstances ...
Oct 9, 2023
0
1
An animal sedative approved by the FDA, xylazine has now made its way to the illicitly manufacture fentanyl supply, creating new challenges for physicians caring for its victims.
Oct 9, 2023
0
21
